GO
Loading...

Lightning Round: Alexion Pharma, Sonic, Lululemon Athletica and More

Wednesday, 18 Jul 2012 | 6:47 PM ET

Alexion Pharma : This was last year's "Mad Money" Home Run Derby winner. And with Vivus higher and Mellanox Tech up 50 percent on the quarter, Cramer wants you to stick with it.

Sonic : The stock's had a nice little run-up, but Cramer says "You ain’t seen nothing yet!" He thinks Sonic still goes higher.

Lululemon Athletica : Cramer says that old apparel complex is coming back and he wants to own Lululemon right now.

FirstEnergy : While Cramer thinks FE is one terrific utility, he still likes Duke Energy more at this point.

Carnival : "[The stock] is okay but it lacks a catalyst," Cramer said. He likes Disney better, since the company not only has a cruise line "that would be humming" but also owns ESPN.

Lightning Round
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Amarin : Amarin is one of a handful of biotechs Cramer’s willing to bet on. "If we get some good news on that, I want you to ring the register," he said.

(RELATED: Cramer's Top Dividend Stocks)

Allot Communications : This stock is a little played out, he said. Cramer liked it at $15.60 but after the recent run-up it's had, he doesn’t want to chase it right now.

Altera : Altera’s fine and Cramer wants to hold onto it for the cycle, even though everyone else is giving up, he said.

When this story was published, Cramer's charitable trust owned Disney.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
ALLT
---
ALTR
---
ALXN
---
AMRN
---
CCL
---
DUK
---
FE
---
LULU
---
ZZE
---
SONC
---
VVUS
---

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.